News & Articles

The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring

SARS-CoV-2 testing is a powerful tool for curbing the COVID-19 pandemic and safely reopening schools and businesses

The license from ERS expands ZeClinics CRISPR IP portfolio and increases the validity and potency of zebrafish models for the drug discovery process

The research brings a deeper understanding about how fructose could be linked to diabetes and obesity

International experts are joining forces to combat vaccine hesitancy by tackling its root cause

The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA

Companion diagnostic can help guide treatment decisions in cases of NSCLC

Neuroscientists can now screen over 3,000 neurons from a NeuroHTS microplate in under 30 minutes with the ImageXpress Pico Automated Cell Imaging System

Emergency Use Listing granted to AstraZeneca and Serum Institute of India enabling global access to the vaccine

Focusing on innate immunity opens way for precision medicine approaches to AD

Company expands portfolio of SARS-CoV-2 testing solutions with rapid antigen test benchmarked against gold standard RT-PCR

Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency

Discover the latest technologies and techniques to aid research into the biology, detection, and prevention of SARS-CoV-2 infection

New partnership broadens access to oncology treatments across Latin America, Asia, Africa and the Western Pacific

Partnership aims to accelerate CE marking of Avacta’s SARS-CoV-2 rapid antigen test and support COVID-19 testing

The test could be used to assess antibody response against the native spike protein of SARS-CoV-2 following COVID-19 vaccination

This effort will study virus variants in the UK and South Africa and what that means for the transmission of SARS-CoV-2

Researchers have used Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others

Advancement can enable greater certainty for providers and better outcomes for patients

Expanded list of instruments and reagents allows more options for labs running CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay

In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus

The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases